SCHEMBL31228248

SCHEMBL31228248

N#Cc1cn([C@@H]2O[C@](F)(CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 11/20 0.60
▸ DOT1L Q8TEK3 3/20 0.50
▸ PRMT5 O14744 3/20 0.49
▸ PRMT3 O60678 1/20 0.49
▸ DNMT1 P26358 1/20 0.49
▸ EHMT2 Q96KQ7 1/20 0.49
▸ PAX8 Q06710 2/20 0.42
▸ WDR77 Q9BQA1 2/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ GALR3 O60755 1/20 0.41
▸ S1PR4 O95977 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27559528 0.87 ADK (0.62) ADKDOT1LPRMT5PRMT3DNMT1
SCHEMBL31228253 0.85 ADK (0.51) ADKDOT1LPRMT5PAX8WDR77
SCHEMBL31228437 0.84 ADK (0.50) ADKDOT1LPRMT5PAX8NPC1
SCHEMBL31228180 0.84 ADK (0.50) ADKDOT1LPRMT5PAX8WDR77
SCHEMBL31228230 0.82 ADK (0.48) ADKDOT1LPRMT5PAX8WDR77
SCHEMBL31228211 0.82 ADK (0.59) ADKDOT1LPRMT5PAX8WDR77
SCHEMBL31228418 0.82 ADK (0.39) ADKDOT1LPRMT5PRMT3DNMT1
SCHEMBL19859768 0.79 ADK (0.47) ADKDOT1LPRMT5PRMT3DNMT1
Toyocamycin SCHEMBL20438004 0.78 ADK (0.80) ADKDOT1LPRMT5PRMT3DNMT1
Toyocamycin SCHEMBL6674952 0.78 ADK (0.80) ADKDOT1LPRMT5PRMT3DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback